Today we bring you #ChedHER: a day full of live programming celebrating women who are changing the game. In each hour, we'll focus on a different theme and introduce a new guest co-host.
In Opening Bell, we highlight women in business and finance and then women entrepreneurs. Anjali Kumar, Cheddar's Chief People Officer and General Counsel, kicks off the day's coverage with Kristen Scholer.
We hear from Dia Simms, president of Combs Enterprises, about how she climbed the ladder and got to where she is today. Simms started as Sean Combs' assistant in 2005 and gradually worked her way up the ranks. At times, Simms oversaw Combs' liquor, entertainment, and clothing properties, and also played a big role in the creation and launch Ciroc Vodka.
We also talk to Whitney Casey, founder of the women's tech start-up Finery. Casey and her partner Brooklyn Decker just closed on a $5 million round of funding. Finery is the world's first automated online operating system for wardrobes. Casey discusses the challenges she faced trying to get male-dominated VC firms to invest in a female-focused tech company.
We spoke with a farmer about how tariffs, trade policy, drought, and packer consolidation are reshaping the economics of American ranching and farming.
John Serafini, CEO of Hawkeye 360, breaks down the company’s 87% revenue growth, global demand for space-based intelligence and plans to scale its business.
Dan Niles, Founder and Portfolio Manager at Niles Investment Management, breaks down NVIDIA’s blowout earnings, 70% growth forecast and AI spending boom.
Edwin Cywinski, CEO of SunScout Holding Limited, explains how solar-powered robotic mowers are transforming lawn care and the company’s plans to scale.
Nathan Bomey, Business Reporter at Axios and author of The Axios Closer newsletter, explains why Wall Street is turning NVIDIA’s AI chips into financial assets.
Jamie Siminoff, Founder and Chief Inventor of Ring, explains the company’s new TAKE encryption standard and its push to put privacy and video data control first
Xavier Martinez, News Associate at The Wall Street Journal, breaks down Moderna’s mRNA ambitions, its pipeline beyond COVID-19 and the challenges ahead.
